S&P 500   3,298.46 (+1.60%)
DOW   27,173.96 (+1.34%)
QQQ   271.56 (+2.32%)
AAPL   112.28 (+3.75%)
MSFT   207.82 (+2.28%)
FB   254.82 (+2.12%)
GOOGL   1,439.06 (+1.14%)
AMZN   3,095.13 (+2.49%)
TSLA   407.34 (+5.04%)
NVDA   514.95 (+4.26%)
BABA   271.09 (+0.50%)
CGC   14.17 (-0.70%)
GE   6.11 (+0.99%)
MU   49.14 (-0.67%)
AMD   78.06 (+2.95%)
T   28.04 (+0.00%)
F   6.51 (-2.25%)
ACB   5.05 (-2.88%)
GILD   62.25 (+0.00%)
NFLX   482.88 (+2.07%)
DIS   124.00 (+1.23%)
BAC   23.49 (+0.64%)
BA   156.03 (+6.83%)
S&P 500   3,298.46 (+1.60%)
DOW   27,173.96 (+1.34%)
QQQ   271.56 (+2.32%)
AAPL   112.28 (+3.75%)
MSFT   207.82 (+2.28%)
FB   254.82 (+2.12%)
GOOGL   1,439.06 (+1.14%)
AMZN   3,095.13 (+2.49%)
TSLA   407.34 (+5.04%)
NVDA   514.95 (+4.26%)
BABA   271.09 (+0.50%)
CGC   14.17 (-0.70%)
GE   6.11 (+0.99%)
MU   49.14 (-0.67%)
AMD   78.06 (+2.95%)
T   28.04 (+0.00%)
F   6.51 (-2.25%)
ACB   5.05 (-2.88%)
GILD   62.25 (+0.00%)
NFLX   482.88 (+2.07%)
DIS   124.00 (+1.23%)
BAC   23.49 (+0.64%)
BA   156.03 (+6.83%)
S&P 500   3,298.46 (+1.60%)
DOW   27,173.96 (+1.34%)
QQQ   271.56 (+2.32%)
AAPL   112.28 (+3.75%)
MSFT   207.82 (+2.28%)
FB   254.82 (+2.12%)
GOOGL   1,439.06 (+1.14%)
AMZN   3,095.13 (+2.49%)
TSLA   407.34 (+5.04%)
NVDA   514.95 (+4.26%)
BABA   271.09 (+0.50%)
CGC   14.17 (-0.70%)
GE   6.11 (+0.99%)
MU   49.14 (-0.67%)
AMD   78.06 (+2.95%)
T   28.04 (+0.00%)
F   6.51 (-2.25%)
ACB   5.05 (-2.88%)
GILD   62.25 (+0.00%)
NFLX   482.88 (+2.07%)
DIS   124.00 (+1.23%)
BAC   23.49 (+0.64%)
BA   156.03 (+6.83%)
S&P 500   3,298.46 (+1.60%)
DOW   27,173.96 (+1.34%)
QQQ   271.56 (+2.32%)
AAPL   112.28 (+3.75%)
MSFT   207.82 (+2.28%)
FB   254.82 (+2.12%)
GOOGL   1,439.06 (+1.14%)
AMZN   3,095.13 (+2.49%)
TSLA   407.34 (+5.04%)
NVDA   514.95 (+4.26%)
BABA   271.09 (+0.50%)
CGC   14.17 (-0.70%)
GE   6.11 (+0.99%)
MU   49.14 (-0.67%)
AMD   78.06 (+2.95%)
T   28.04 (+0.00%)
F   6.51 (-2.25%)
ACB   5.05 (-2.88%)
GILD   62.25 (+0.00%)
NFLX   482.88 (+2.07%)
DIS   124.00 (+1.23%)
BAC   23.49 (+0.64%)
BA   156.03 (+6.83%)
Log in
CVE:SVS

Solarvest Bioenergy Stock Forecast, Price & News

C$0.10
-0.02 (-16.00 %)
(As of 09/23/2020 03:50 PM ET)
Add
Compare
Today's Range
C$0.10
Now: C$0.11
C$0.11
50-Day Range
C$0.09
MA: C$0.11
C$0.13
52-Week Range
C$0.02
Now: C$0.11
C$0.18
Volume49,400 shs
Average Volume23,800 shs
Market CapitalizationC$4.55 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally. Its algal-based production systems are used to produce nutritional nutraceuticals, pharmaceutical oils, and biologic active ingredients/therapies. The company is developing algae strains for the food enhancement and nutraceutical markets; and producing proteins as a therapeutic. It has a collaborative research and development agreement with FSD Pharma Inc. to develop algae-based pharma-grade cannabinoids. Solarvest BioEnergy Inc. was incorporated in 2005 and is based in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.18 out of 5 stars


Industry, Sector and Symbol

Industry Conglomerates
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+1-604-6843323

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$0.02 per share
Book ValueC($0.08) per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$4.55 million
Next Earnings DateN/A
OptionableNot Optionable
C$0.10
-0.02 (-16.00 %)
(As of 09/23/2020 03:50 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SVS News and Ratings via Email

Sign-up to receive the latest news and ratings for SVS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Solarvest Bioenergy (CVE:SVS) Frequently Asked Questions

How has Solarvest Bioenergy's stock price been impacted by COVID-19?

Solarvest Bioenergy's stock was trading at C$0.08 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SVS stock has increased by 31.3% and is now trading at C$0.11.
View which stocks have been most impacted by COVID-19
.

Who are some of Solarvest Bioenergy's key competitors?

Who are Solarvest Bioenergy's key executives?

Solarvest Bioenergy's management team includes the following people:
  • Mr. Kenneth Anthony Cawkell B.A., LL.B., Chairman & Corp. Sec. (Age 68)
  • Mr. Gerri J. Greenham, Pres, CEO & Director (Age 68)
  • Mr. Ching-Hiang Heng, Chief Financial Officer (Age 73)
  • Mr. Garth Greenham, Chief Operating Officer

What is Solarvest Bioenergy's stock symbol?

Solarvest Bioenergy trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SVS."

How do I buy shares of Solarvest Bioenergy?

Shares of SVS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Solarvest Bioenergy's stock price today?

One share of SVS stock can currently be purchased for approximately C$0.11.

How big of a company is Solarvest Bioenergy?

Solarvest Bioenergy has a market capitalization of C$4.55 million.

What is Solarvest Bioenergy's official website?

The official website for Solarvest Bioenergy is www.solarvest.ca.

How can I contact Solarvest Bioenergy?

Solarvest Bioenergy's mailing address is 439 Helmcken St, VANCOUVER, BC V6B 2E6, Canada. The company can be reached via phone at +1-604-6843323.

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.